BSECompany UpdateResults17 Aug 2026
Camlin Fine Sciences Ltd
Transcript of the Earnings Call Q1FY27
Camlin Fine Sciences Ltd has announced its Q1FY27 earnings, with revenues of INR5,199 million, a 28% increase from the last year's quarter. However, margins have decreased due to increased raw material costs.
BSECompany UpdateResults12 Aug 2026
Camlin Fine Sciences Ltd
Newspaper Publication - Unaudited Financial Results for the quarter ended June 30, 2026.
Camlin Fine Sciences Ltd has announced unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 100 before tax and Rs. 219 after tax. The company's total income from operations was Rs. 1,365, and its earnings per share (EPS) was Rs. 0.14.
BSECompany UpdateResults11 Aug 2026
Camlin Fine Sciences Ltd
Investor Call Recording Q1 FY27
Camlin Fine Sciences Ltd has made available the audio recording of its conference call on Q1 FY27 un-audited financial results, held on August 11, 2026, at its website.
BSECompany UpdateResults11 Aug 2026
Camlin Fine Sciences Ltd
Investor Presentation Q1 FY27
Camlin Fine Sciences Ltd has announced its Q1 FY27 financial results, with revenue increasing by 28% YoY to Rs 5,199 mn, and EBITDA margin decreasing by 159 bps to 3.4%. The company has also provided an investor presentation highlighting its financial performance and outlook for FY27.
BSEBoard MeetingResults11 Aug 2026
Camlin Fine Sciences Ltd
Outcome of Board Meeting dated August 11, 2026
Camlin Fine Sciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net loss of Rs. 123.12 crore and a total comprehensive income of Rs. 86.28 crore. The company's revenue from operations was Rs. 2,224.86 crore, and its expenses were Rs. 2,425.60 crore.
BSEResultResults11 Aug 2026
Camlin Fine Sciences Ltd
Un-audited Financial Results for the quarter ended June 30, 2026
Camlin Fine Sciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a standalone profit/loss of ₹123.12 crore and a consolidated profit/loss of ₹-336.22 crore.
BSEAGM/EGM11 Aug 2026
Camlin Fine Sciences Ltd
Scrutinizers Report with Voting Results of 33rd AGM
Camlin Fine Sciences Ltd held its 33rd Annual General Meeting on August 11, 2026, through video conferencing, where all items of business were transacted and passed with requisite majority through e-voting. The meeting was chaired by Mr. Ashish Dandekar, and the voting results were made available on the company's website and NSDL.
BSEAGM/EGM11 Aug 2026
Camlin Fine Sciences Ltd
Proceedings of the 33rd AGM
Camlin Fine Sciences Ltd held its 33rd AGM on August 11, 2026, through video conferencing. The meeting was attended by the requisite quorum, and all items of business were transacted and passed by the shareholders with the requisite majority. The voting results were made available on the company's website and on the NSDL website.
BSECompany UpdateResults4 Aug 2026
Camlin Fine Sciences Ltd
Schedule of Investor Meet - Q1FY27 Earnings Call
Camlin Fine Sciences Ltd has scheduled a conference call on August 11, 2026, to discuss its un-audited financial results for Q1FY27. The call will be attended by the senior management team and will cover the company's operational and financial performance.
BSEBoard MeetingResults4 Aug 2026
Camlin Fine Sciences Ltd
Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
Camlin Fine Sciences Ltd has scheduled a Board Meeting on August 11, 2026, to consider and approve the Un-audited Standalone and Consolidate Financial Results for the quarter ended June 30, 2026.
BSEInsider Trading / SASTPledge28 Jul 2026
Camlin Fine Sciences Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 28, 2026 for Ashish Subhash Dandekar
Camlin Fine Sciences Ltd received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Ashish Subhash Dandekar regarding the release of pledge of Equity Shares of the Company.